Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02840110 · ClinicalTrials.gov registry record
Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product
A clinical trial, sponsored by Cogent Biosciences.
- Terminated
- Registry status
- 22
- Enrollment target
NCT02840110: Clinical Trial study, sponsored by Cogent Biosciences.
NCT02840110 is a clinical trial that was terminated before completion, run by Cogent Biosciences. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02840110 was terminated before completion, sponsored by Cogent Biosciences.
- TERMINATED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Subjects treated with an ACTR product may participate in this long-term follow-up study after the completion of the final scheduled visit in the parent clinical study or other investigational setting, such as compassionate use, named patient Investigational New Drug application, expanded access program, or equivalent setting. No investigational product or treatment will be administered in this study. These subjects will be followed for safety monitoring on a schedule of decreasing frequency through 15 years post-ACTR treatment, in accordance with US FDA Regulatory guidance pertaining to long-term safety follow-up for study subjects receiving recombinant DNA-containing investigational products.
Interventions
- OTHER ACTR T Cell Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-10 |
| Est. Completion | 2021-02-23 |
Why NCT02840110 stopped before completion
NCT02840110 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ACTR T Cell Product is the first listed.
NCT02840110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02840110 about?
NCT02840110 is a clinical study titled "Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product". Subjects treated with an ACTR product may participate in this long-term follow-up study after the completion of the final scheduled visit in the parent clinical study or other investigational setting, such as compassionate use, named patient Investigational New Drug application, expanded access prog...
What is the current status of trial NCT02840110?
This trial is currently terminated. The enrollment target is 22 participants. The study started on 2016-10. Estimated completion is 2021-02-23.
What interventions are being tested in trial NCT02840110?
The interventions under investigation include: ACTR T Cell Product (OTHER).
Who is sponsoring clinical trial NCT02840110?
This trial is sponsored by Cogent Biosciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia